Dabigatran as a Treatment Option for Heparin‐Induced Thrombocytopenia-Reference-Cited by-同舟云学术

Dabigatran as a Treatment Option for Heparin‐Induced Thrombocytopenia

Published:2018-10-04 Issue:1 Volume:59 Page:107-111
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Nasiripour Somayyeh¹,Saif Maryam²,Farasatinasab Maryam³,Emami Sepide⁴,Amouzegar Atefeh⁵,Basi Ali⁶,Mokhtari Majid⁷

Affiliation:

1. Department of Clinical Pharmacy, School of Pharmacy‐International CampusIran University of Medical Sciences Tehran Iran

2. Department of Internal Medicine, Firoozgar Clinical Research Development CenterIran University of Medical Sciences Tehran Iran

3. Department of Clinical Pharmacy, Firoozgar Clinical Research Development Center, School of Pharmacy‐International CampusIran University of Medical Sciences Tehran Iran

4. Department of Cardiology, Firoozgar HospitalIran University of Medical Sciences Tehran Iran

5. Department of Nephrology, Firoozgar Clinical Research Development CenterIran University of Medical Sciences Tehran Iran

6. Department of Hematology, Firoozgar Clinical Research Development CenterIran University of Medical Sciences Tehran Iran

7. Department of MedicineShahid Beheshti University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1300

Reference20 articles.

1. Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin

2. A 14-year study of heparin-induced thrombocytopenia

3. Clinical features of heparin‐induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients;Greinacher A;Thromb Haemost,2005

4. Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study

5. Heparin‐Induced Thrombocytopenia 2000 Marcel Dekker New York T Warkentin T Warkentin A Greinacher Clinical picture of heparin‐induced thrombocytopenia 43 80

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Heparin-Induced Thrombocytopenia: A Contemporary Review;Journal of Clinical Medicine;2024-08-09

2. Results of an international survey of opinions on the definitions and treatments for heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology;Journal of Thrombosis and Haemostasis;2024-06

3. DrugRepoBank: a comprehensive database and discovery platform for accelerating drug repositioning;Database;2024

4. An Open‐Label, Single‐Arm, Pilot Intervention Study to Assess the Efficacy and Safety of Apixaban in Heparin‐Induced Thrombocytopenia;The Journal of Clinical Pharmacology;2022-06-25

5. Dabigatran as alternative therapy in prothrombotic immune thrombocytopenia induced by the AstraZeneca SARS-Cov-2 vaccine;Journal of Cardiology & Current Research;2021-11-10